TORONTO, Sept. 19, 2017 (GLOBE NEWSWIRE) — TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) announces that it has determined not to proceed with the placement of the convertible debenture that was previously announced on August 23, 2017.

About TerrAscend

TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned subsidiaries, Solace Health Inc. (“Solace Health”), a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, Terra Health Network Inc. (“Terra Health”), a clinical support program and education platform led by health care professionals, and Solace Rx Inc. (“SolaceRx”), a drug preparation premises for non-cannabis formulations. Please visit www.TerrAscend.com for more information about the Company.

Original press release: https://globenewswire.com/news-release/2017/09/19/1124934/0/en/TerrAscend-Provides-Update-on-Convertible-Debenture.html

Published by NCV Newswire

The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.